View drug registration information details.
Items | Registration information |
ID | 902 |
No | 902 |
Brand Name | DACOMAKS 45 |
Ingredients | DACOMITINIB 45 MG |
Dosage Form | TABLET |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | 30 TABLETS/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | FOR FIRSTLINE TREATMENT OF PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR EXON 19 DELETION OR EXON 21 L858R SUBSTITUTION MUTATION |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | BLUE ROUND, FILM COATED TABLET |
Note | |
License Owner | FACTORY NO.2 |
Manufacturer | FACTORY NO. 2 |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 12 L 1275/24 |
FDD Registration Date | 13-JAN-2025 |
Expiry Date | 12-JAN-2030 |
Back to drug list
|